Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:ICPT’

Alex Denner Sarissa Capital

Is Intercept Pharmaceuticals Inc (ICPT) A Good Stock To Buy?

“The end to the U.S. Government shutdown, reports of progress on China-U.S. trade talks, and the Federal Reserve’s confirmation that it did not......(read more)
Samuel Isaly Orbimed Advisors

Here’s What Hedge Funds Think About Intercept Pharmaceuticals Inc (ICPT)

While the market driven by short-term sentiment influenced by uncertainty regarding the future of the interest rate environment in the US, declining oil......(read more)
Alex Denner Sarissa Capital

Hedge Funds Are Betting On Intercept Pharmaceuticals Inc (ICPT)

Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Intercept Pharmaceuticals Inc (ICPT): Are Hedge Funds Right About This Stock?

Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They......(read more)
under, armour, running, shoes, UA

Investors Are Buzzing About These 5 Morning Movers

In contrast to yesterday’s action, the major indexes are all green today, with crude futures leading the way, up by 5%. Among the stocks generating......(read more)
stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart

Why Are These Stocks Among Today’s Losers?

This week’s roller coaster is coming to and end with a bang, as U.S. stocks are deep in the red territory and the Dow is down by triple digits.......(read more)
Wall Street Bull

Why Are These Five Stocks Surging on Tuesday?

Seeing as all three indexes have surged more than 1% in morning trading as the Federal Reserve promises interest rates will still be low for a while,......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Is Intercept Pharmaceuticals Inc (ICPT) A Good Stock To Buy?

After several tireless days we have finished crunching the numbers from the more than 700 13F filings issued by the elite hedge funds and other investment......(read more)
health-846864_1920

These Five Biotech Stocks Ranked Among This UK-based Fund’s Favorites

Cheyne Capital is one of the few non-U.S firms that we track in our database. Managed by its founders, Jonathan Lourie and Stuart Fiertz, Cheyne employs......(read more)
Jacob Gottlieb - Visium Asset Management

Esperion Therapeutics Inc (ESPR), Intercept Pharmaceuticals Inc (ICPT): Visium and OrbiMed’s Recent Activity in Biotech

Stocks in the biotechnology industry have been very active as of late, with companies’ shares registering significant gains. The industry jumped......(read more)
Samuel Isaly Orbimed Advisors

Healthcare Hedge Fund Orbimed’s Top Picks and New Move

According to a Schedule 13D form filed yesterday with the Securities and Exchange Commission, Samuel Islay‘s Orbimed Advisors has slashed its stake......(read more)
Steve Cohen SAC CAPITAL ADVISORS

Applied Genetic Technologies Corp (AGTC): Steve Cohen Starts New Stake With 5.8% of The Company’s Outstanding Stock

Steve Cohen’s Point72 Asset Management disclosed today a new position in Applied Genetic Technologies Corp (NASDAQ:AGTC). The funds affiliated with......(read more)
Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

Intercept Pharmaceuticals Inc. (ICPT), Bristol-Myers Squibb Co (BMY), Biogen Idec Inc (BIIB): Orbimed Advisors Top Stocks in Q2

Orbimed Advisors, led by Samuel Isaly, recently published its 13F filing with the U.S. Securities and Exchange Commission. For the second quarter of 2014......(read more)
Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

Orbimed Advisors Further Cuts Exposure To Intercept Pharmaceuticals Inc. (ICPT)

Orbimed Advisors, led by Samuel Isaly, has disclosed cutting its position in Intercept Pharmaceuticals Inc. (NASDAQ:ICPT). According to the filing, Orbimed......(read more)
Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

Intercept Pharmaceuticals Inc. (ICPT)’s Positive Liver Cure Overshadows Dismal Second Quarter Results

Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) continues to soar in the market after the release of positive clinical data, which showed its drug for a......(read more)
Gilead Sciences, Inc. (NASDAQ:GILD)

NASH a Big Opportunity For Gilead Sciences, Inc. (GILD)

After being a dominant player in the hepatitis C market with its drug Sovaldi, Gilead Sciences, Inc. (NASDAQ:GILD) is now eyeing to monetize from the......(read more)
Andreas Halvorsen

Triumph Group Inc (TGI), Intercept Pharmaceuticals Inc (ICPT), Zynga Inc (ZNGA): Viking Global’s Top 5 Small-Cap Picks

Small-cap picks from individual funds might provide investors with attractive investment options. In this article we will look into Andreas Halvorsen’......(read more)
Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

Orbimed Advisors Cuts Stake In Intercept Pharmaceuticals Inc (ICPT)

Orbimed Advisors is limiting exposure to Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after selling approximately 81,305 shares in one transaction at......(read more)
Steve Cohen SAC CAPITAL ADVISORS

Second Wave of Moves from SAC Capital

In another set of filing with the Securities and Exchange Commission, Steven Cohen and his fund, SAC Capital Advisors, have revealed a number of changes......(read more)
Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

Visium Asset Management Ups Stake in Skyrocketing Intercept Pharmaceuticals Inc (ICPT)

Jacob Gottlieb‘s Visium Asset Management has increased its stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), according to an amended filing......(read more)
Steven Cohen

Steve Cohen, SAC Capital Reveal 5.3% Stake in Intercept Pharmaceuticals

Steve Cohen‘s SAC Capital has just revealed a 5.3% stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), a new filing with the SEC indicates.......(read more)
Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

Samuel Isaly’s Orbimed Advisors Sells Some Intercept Pharmaceuticals Stock at $62.50/Share

Orbimed Advisors, Intercept Pharmaceuticals: Samuel Isaly and his hedge fund, Orbimed Advisors, is focused on healthcare stocks. They recently reported......(read more)
Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

Orbimed Downgrades its Position in Intercept Pharmaceuticals

Orbimed Advisors, Intercept Pharmaceuticals: In a recent SEC filing, Samuel Isaly and his hedge fund, Orbimed Advisors, reported decreasing their holding......(read more)
Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?

Should Pacira Pharmaceuticals Inc (NASDAQ:PCRX) investors track the following data? To the average investor, there are many methods market participants......(read more)
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH)

What Hedge Funds Think About Kythera Biopharmaceuticals Inc (KYTH)

To the average investor, there are tons of methods market participants can use to track publicly traded companies. Two of the most useful are hedge fund......(read more)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

This Metric Says You Are Smart to Buy Neurocrine Biosciences, Inc. (NBIX)

Is it smart to be bullish on Neurocrine Biosciences, Inc. (NASDAQ:NBIX)? In the financial world, there are dozens of indicators investors can use to......(read more)
Impax Laboratories Inc (NASDAQ:IPXL)

Hedge Funds Are Buying Impax Laboratories Inc (IPXL)

Is Impax Laboratories Inc (NASDAQ:IPXL) a good investment? At the moment, there are tons of indicators shareholders can use to analyze publicly traded......(read more)
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

Hedge Funds Aren’t Crazy About Rigel Pharmaceuticals, Inc. (RIGL) Anymore

Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) a good investment? In the eyes of many investors, hedge funds are seen as useless, outdated investment tools......(read more)
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)

Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?

To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies. Some of the most under-the-radar are......(read more)
Nektar Therapeutics (NASDAQ:NKTR)

Nektar Therapeutics (NKTR), Stemline Therapeutics Inc (STML): Humongous Health-Care Stocks This Week

While the market jittered this week over what the Federal Reserve will do next, some stocks didn’t flinch. The fortunate investors were those who......(read more)

Hedge Funds Are Buying Endocyte, Inc. (ECYT)

Is Endocyte, Inc. (NASDAQ:ECYT) a marvelous investment today? The best stock pickers are in a bullish mood. The number of long hedge fund positions inched......(read more)

Hedge Funds Are Betting On Kythera Biopharmaceuticals Inc (KYTH)

Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) was in 10 hedge funds’ portfolio at the end of March. KYTH investors should be aware of an increase......(read more)
Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

Here is What Hedge Funds Think About Pacira Pharmaceuticals Inc (PCRX)

Is Pacira Pharmaceuticals Inc (NASDAQ:PCRX) a superb investment right now? Hedge funds are in an optimistic mood. The number of long hedge fund positions......(read more)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Neurocrine Biosciences, Inc. (NBIX): Are Hedge Funds Right About This Stock?

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was in 16 hedge funds’ portfolio at the end of the first quarter of 2013. NBIX has experienced an increase......(read more)
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

Hedge Funds Are Betting On Rigel Pharmaceuticals, Inc. (RIGL)

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) investors should pay attention to an increase in hedge fund interest in recent months. According to most shareholders......(read more)

Hedge Funds Are Buying Aegerion Pharmaceuticals, Inc. (AEGR)

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was in 14 hedge funds’ portfolio at the end of the fourth quarter of 2012. AEGR has seen an increase......(read more)

Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?: Impax Laboratories Inc (IPXL), Pacira Pharmaceuticals Inc (PCRX)

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was in 14 hedge funds’ portfolio at the end of December. AEGR has experienced an increase in enthusiasm......(read more)

Endocyte, Inc. (NASDAQ:ECYT), Kythera Biopharmaceuticals Inc (NASDAQ:KYTH): Should You Avoid Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)?

Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) a safe stock to buy now? Prominent investors are in a bearish mood. The number of long hedge fund bets dropped......(read more)